Some progress has been made in the U.S. fight against HIV, with new infections falling among white gay and bisexual men over the past decade. But their Black and Hispanic counterparts did not see that advance, health officials say.
The continuing inequities show up in a new report from the U.S. Centers for Disease Control and Prevention.
Sex Ed -- it's been a staple of public education for decades, but new research shows that only half of American teens are getting instruction that meets minimum standards.
"The findings show that most adolescents are not receiving sex education that will enable them to manage their sexual lives," said study author Leslie Kantor, chair of the Department of Urban-Global Public Health at Rut...
There are two ways that HIV patients' bodies can keep the virus under control after they stop antiretroviral therapy, a new study shows.
The findings could point to ways to help people with HIV keep the virus in remission without having to keep taking medications that can have long-term side effects, according to researchers at the U.S. National Institute of Allergy and Infectious Disease...
COVID-19 vaccination triggers a strong immune response in people with HIV, meaning they're likely protected against the coronavirus, a new, small study shows.
"Previous research has suggested a suboptimal response to COVID-19 vaccines in people living with HIV; however, these studies did not fully characterize and define that response, both for cellular [where the immune system directly a...
When the antiretroviral regimen known as pre-exposure prophylaxis, or PrEP, was launched nearly a decade ago, patients were suddenly able to achieve near-complete protection against contracting HIV by taking just one pill a day.
But there's a big hitch: Not everyone is equally diligent about sticking to that once-a-day daily pill regimen, and when doses are missed PrEP's protective shield...
The two HIV prevention drugs available in the United States are equally safe and effective, and the biggest difference between them is price, a new study contends.
However, a sizable minority of patients have switched from the older and cheaper "preexposure prophylaxis" (PrEP) formulation to the newer and much pricier one. In many cases that switch might not have been warranted, the resea...
Ernie Mundell and Robert Preidt HealthDay Reporters
Testing HIV-positive is no longer a certain death sentence, and new research shows that Americans who have HIV today have life spans similar to those of their peers without the virus.
"In the early days of the AIDS pandemic, getting a diagnosis with AIDS was incredibly bad news and the prognosis for survival was really poor, and that's not true today," said lead author Jessie Edwards, a r...
People living with HIV have to take powerful drug cocktails to keep their disease in check, but a new study finds they also need to worry about a doubled risk of sudden cardiac death.
Unlike a heart attack caused by a blocked heart artery, sudden cardiac death can happen without warning and is triggered by an electrical malfunction that causes an irregular heartbeat. Within minutes, there...
Methamphetamine users are at increased risk for physical and mental health problems as well as other substance use disorders, new research shows.
Meth is an illegal and highly addictive stimulant drug that can harm organs such as the heart, lungs, liver and neurological system, and injecting it can increase the risk of infectious diseases, the researchers noted.
Beta-blocker blood pressure medications may increase the risk of heart problems in people with HIV, new research suggests.
For the study, the researchers reviewed the medical records of more than 8,000 U.S. veterans with HIV who developed high blood pressure between 2000 and 2018. Of those, around 6,500 had never been diagnosed with heart or blood vessel problems.
A commonly prescribed component of the life-saving antiretroviral drug cocktails used to treat HIV may trigger weight gain, new research warns.
The concern stems from tracking patients taking antiretroviral therapy (ART). Since the mid-1990s, the therapy has relied on various drug combinations to essentially outwit HIV, controlling viral loads and turning a once-deadly infection into a ma...
A vaginal ring that slowly releases an antiviral medication could protect women against HIV for up to three months, a preliminary trial suggests.
It assessed two formulations of a vaginal ring that releases the antiretroviral dapivirine in the vagina over the course of 90 days. One version contained 100 milligrams (mg) of dapivirine and the other contained 200 mg.
In another sign that the Affordable Care Act (ACA) has been good for Americans' health, a new study finds that a large number of undiagnosed HIV cases in the United States came to light after Medicaid's expansion under the health insurance law.
Not only that, there was also an increase in the use of HIV prevention services, the researchers said.
According to 2018 data, one in five people in the United States probably carries a sexually transmitted infection, the U.S. Centers for Disease Control and Prevention says.
On any given day in 2018, nearly 68 million people had a sexually transmitted disease, according to the new CDC report. There were 26 million new cases that year. The agency refers to these diseases -- such as HIV, sy...
The first monthly shots to treat adults with HIV were approved by the U.S. Food and Drug Administration on Thursday.
"Currently, the standard of care for patients with HIV includes patients taking daily pills to adequately manage their condition. This approval will allow some patients the option of receiving once-monthly injections in lieu of a daily oral treatment regimen," said Dr. John...
U.S. and Canadian restrictions on cornea donations from gay and bisexual men prevent thousands of vision-restoring transplants and need to be changed, researchers say.
A corneal transplant can cure some forms of blindness and visual impairment. The United States bans men from donating if they have had gay sex in the past five years; Canada has a 12-month restriction.
About one-third of people prescribed drugs to prevent HIV stopped taking the medications when they were forced to stay home due to the coronavirus pandemic, a new survey finds. The reason, they said: They weren't having sex.
Many discontinued the drugs without their doctor's say-so, which has experts concerned.
"Reducing the number of new HIV transmissions and ensuring acces...
People with HIV who were hospitalized with COVID-19 didn't have worse results than COVID-19 patients without HIV, new research shows.
"Throughout the pandemic, we've suspected that immunocompromised patients, such as those with HIV, could be at a higher risk for infection and suffer more severe outcomes, but without data on how COVID-19 affects patients with HIV specifically, clinical...
Scientists are reporting an early step toward an HIV drug that could potentially be taken only a couple of times per year.
A single injection of the experimental drug, called lenacapavir, was able to lower blood levels of HIV in a small group of patients. And it was capable of maintaining active levels in the blood for more than six months.
Women with HIV who experience persistently high levels of stress or depression have a significantly greater risk of plaque building up in their arteries than those who rarely or never report these symptoms, a new study finds.
The study, published Monday in the Journal of the American Heart Association, analyzed previously collected data for 700 women with and without HIV who did not hav...
HIV may not be the death sentence it was 20 or 30 years ago, but people who are HIV-positive still face much shorter lives than other adults -- even if they're treated with medications that make the virus undetectable.
A new study reports that people who were HIV-positive at age 21 had an average life expectancy of 56 years -- nine years fewer than their virus-free peers.
An experimental vaccine seems to give monkeys extended protection from an HIV-like infection -- by "waking up" an arm of the immune system that vaccines normally do not.
Experts cautioned that animal research often does not pan out in humans. The decades of work toward an HIV vaccine has been a clear example. But, researchers said, this vaccine works differently, targeting two "arms" ...
Researchers have reformulated an HIV medication into a version they hope can eventually be taken as infrequently as once a year.
The work is only in the early stages, having been studied in lab animals. But the goal is to create an HIV drug that can be injected annually -- offering protection from infection or control of the virus in people who already have it.
Young people with HIV have much lower rates of viral suppression than adults with the AIDS-causing virus, a new U.S. study finds.
Viral suppression means that HIV has been reduced to undetectable levels. Maintaining viral suppression for at least six months prevents the sexual transmission of HIV and helps people with the virus remain healthy.
Too few Americans are getting tested or treated for HIV, a new government report shows.
"The time is now to end HIV in America. We have the right tools, the right data and the right leadership to get this done," said Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention.
"Those living with HIV are our best teachers. They are key to helping us r...
Giving HIV-suppressing medications to infected babies within hours of birth is feasible and might help doctors eliminate hidden reservoirs of the virus, new research suggests.
"Strategies to test and treat infants immediately after birth may improve outcomes," said study senior author Dr. Mathias Lichterfeld. He's an associate physician of infectious diseases at Brigham and Women's H...
Children born to women who take the HIV drug efavirenz during pregnancy have a higher risk of small head size -- a birth defect known as microcephaly -- compared to babies exposed to other HIV drugs in the womb, new research shows.
Prenatal exposure to the drug was also linked to developmental delays in children.
But one U.S. expert said the new data shouldn't alarm most HIV...